サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1379443

強度変調放射線治療市場：適応症、放射線タイプ、エンドユーザー別-2023-2030年の世界予測

Intensity Modulated Radiotherapy Market by Indication (Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer), Radiation Type (Carbon-Ion Radiation, Electron Radiation, Photon Radiation), End-User - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
強度変調放射線治療市場：適応症、放射線タイプ、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

強度変調放射線治療市場は、2022年の21億9,000万米ドルから2030年には33億2,000万米ドルに達すると予測され、予測期間中のCAGRは5.34%です。

強度変調放射線治療の世界市場

主な市場の統計
市場金額：基準年[2022] 21億9,000万米ドル
推定市場金額[2023] 23億米ドル
予測市場金額[2030] 33億2,000万米ドル
CAGR（%） 5.34%
強度変調放射線治療 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは強度変調放射線治療市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.強度変調放射線治療市場の市場規模および予測は？

2.強度変調放射線治療市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.強度変調放射線治療市場における競争戦略の窓とは？

4.強度変調放射線治療市場の最新技術動向と規制の枠組みは？

5.強度変調放射線治療市場における主要ベンダーの市場シェアは？

6.強度変調放射線治療市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中でガンの発生率が増加
      • がん対策に対する政府の取り組みの高まり
      • 世界のヘルスケア支出の増加
    • 抑制要因
      • 高額ながん治療費
    • 機会
      • 強度変調放射線治療における継続的なイノベーション
      • 腫瘍学分野における革新的な治療法の採用の拡大
    • 課題
      • 熟練した専門家の不足
  • 市場セグメンテーション分析
    • 適応症：さまざまな適応症における副作用の軽減と患者の生活の質の向上を目的としたIMRTの応用の拡大
    • 放射線の種類：さまざまな腫瘍サイズ、位置、病期を治療するための汎用性の高い光子療法の優先度が高い
    • エンドユーザー：最新のイノベーションに投資するための資金力が豊富な病院での導入が増加
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 強度変調放射線治療市場適応症別

  • 乳がん
  • 消化器がん
  • 婦人科がん
  • 肺がん
  • 前立腺がん

第7章 強度変調放射線治療市場放射線の種類別

  • 炭素イオン放射線
  • 電子放射線
  • 光子放射線
  • 陽子線

第8章 強度変調放射線治療市場：エンドユーザー別

  • 病院
  • 独立した放射線治療センター

第9章 南北アメリカの強度変調放射線治療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の強度変調放射線治療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの強度変調放射線治療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Accuray Incorporated
    • Aetna Inc.
    • Brainlab AG
    • Elekta AB
    • GE Healthcare
    • Hitachi, Ltd.
    • Mevion Medical Systems
    • PMB by ALCEN group
    • Siemens Healthineers AG
    • Varian Medical Systems, Inc.
    • Xstrahl Group
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. INTENSITY MODULATED RADIOTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. INTENSITY MODULATED RADIOTHERAPY MARKET DYNAMICS
  • FIGURE 7. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 8. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2022 VS 2030 (%)
  • FIGURE 10. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 12. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. INTENSITY MODULATED RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 6. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY CARBON-ION RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY ELECTRON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PHOTON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROTON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 147. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 148. INTENSITY MODULATED RADIOTHERAPY MARKET LICENSE & PRICING
目次
Product Code: MRR-CF6C60CF95C5

The Intensity Modulated Radiotherapy Market is projected to reach USD 3.32 billion by 2030 from USD 2.19 billion in 2022, at a CAGR of 5.34% during the forecast period.

Global Intensity Modulated Radiotherapy Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 2.19 billion
Estimated Year Value [2023] USD 2.30 billion
Forecast Year Value [2030] USD 3.32 billion
CAGR (%) 5.34%
Intensity Modulated Radiotherapy Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Intensity Modulated Radiotherapy Market.

Based on Indication, market is studied across Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer, Lung Cancer, and Prostate Cancer. The Breast Cancer is projected to witness significant market share during forecast period.

Based on Radiation Type, market is studied across Carbon-Ion Radiation, Electron Radiation, Photon Radiation, and Proton Radiation. The Electron Radiation is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Hospitals and Independent Radiotherapy Centers. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.70% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Intensity Modulated Radiotherapy Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Intensity Modulated Radiotherapy Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Intensity Modulated Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Aetna Inc., Brainlab AG, Elekta AB, GE Healthcare, Hitachi, Ltd., Mevion Medical Systems, PMB by ALCEN group, Siemens Healthineers AG, Varian Medical Systems, Inc., and Xstrahl Group.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Intensity Modulated Radiotherapy Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Intensity Modulated Radiotherapy Market?

3. What is the competitive strategic window for identifying opportunities in the Intensity Modulated Radiotherapy Market?

4. What are the latest technology trends and regulatory frameworks in the Intensity Modulated Radiotherapy Market?

5. What is the market share of the leading vendors in the Intensity Modulated Radiotherapy Market?

6. Which modes and strategic moves are suitable for entering the Intensity Modulated Radiotherapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Intensity Modulated Radiotherapy Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of cancer across the world
      • 5.1.1.2. Rise in government initiatives for cancer management
      • 5.1.1.3. Increase in healthcare expenditure globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cancer treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovation in Intensity Modulated Radiotherapy
      • 5.1.3.2. Growing adoption of innovative treatment in the oncology field
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Growing applications of IMRT for reduced side effects and enhanced quality of patient life across various indications
    • 5.2.2. Radiation Type: Higher preferences for versatile photon therapy to treat various tumor sizes, locations, and stages
    • 5.2.3. End-User: Rising adoption by hospitals with greater financial resources to invest in the latest innovations
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Intensity Modulated Radiotherapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Breast Cancer
  • 6.3. Gastrointestinal Cancer
  • 6.4. Gynecological Cancer
  • 6.5. Lung Cancer
  • 6.6. Prostate Cancer

7. Intensity Modulated Radiotherapy Market, by Radiation Type

  • 7.1. Introduction
  • 7.2. Carbon-Ion Radiation
  • 7.3. Electron Radiation
  • 7.4. Photon Radiation
  • 7.5. Proton Radiation

8. Intensity Modulated Radiotherapy Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Independent Radiotherapy Centers

9. Americas Intensity Modulated Radiotherapy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intensity Modulated Radiotherapy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intensity Modulated Radiotherapy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Agreement, Collaboration, & Partnership
      • 12.3.1.1. M42 and QST Sign Agreement to Share Research on Carbon Ion Therapy
      • 12.3.1.2. IBA Partners Exclusively with Apollo Proton Cancer Centre for Providing Proton Beam Therapy Training to Oncologists from Across the Globe
    • 12.3.2. New Product Launch & Enhancement
      • 12.3.2.1. First UK Proton Beam Therapy Trial for Breast Cancer Launches

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Accuray Incorporated
    • 13.1.2. Aetna Inc.
    • 13.1.3. Brainlab AG
    • 13.1.4. Elekta AB
    • 13.1.5. GE Healthcare
    • 13.1.6. Hitachi, Ltd.
    • 13.1.7. Mevion Medical Systems
    • 13.1.8. PMB by ALCEN group
    • 13.1.9. Siemens Healthineers AG
    • 13.1.10. Varian Medical Systems, Inc.
    • 13.1.11. Xstrahl Group
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing